Abstract: The present invention relates to a perfumed powder, odor and moisture absorbing composition, which is safe for use on skin comprising from about 0.1% to about 25%, by weight of the composition, of uncomplexed cyclodextrin; from about 5% to about 60%, by weight of the composition, of a highly effective moisture absorber; a perfume composition selected from the group consisting of from about 0.05% to about 15%, by weight of the odor absorbing composition, of an encapsulated perfume, and from about 0.01% to about 5% by weight of the odor absorbing composition of a free perfume, and mixtures thereof; and a powder carrier. The compositions of the present invention may also contain an additional odor controlling agent selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants.

Abstract: The present invention relates to methods of reducing body and/or vaginal odor comprising the application to skin of perfume-free, odor absorbing compositions comprising from about 0.1% to about 5%, by weight of the composition, of solubilized, water-soluble, uncomplexed cyclodextrin; from about 0.1% to about 36%, by weight of the composition, of an oil phase selected from the group consisting of emollients, moisturizers, skin protectants, and mixtures thereof; one or more surfactants each having a hydrophilic/lipophilic balance of about 8-18 and wherein each surfactant, when combined with an aqueous cyclodextrin solution, provides no less than about 25% a level of odor capture as an aqueous cyclodextrin solution; and an aqueous carrier wherein the odor absorbing composition is safe for use on skin. The odor absorbing compositions may also, preferably, contain an effective amount of hydrophobic antimicrobials.

Abstract: The present invention relates to an oral composition comprising a soluble fluoride ion source, tetrasodium pyrophosphate, calcium peroxide, one or more nonionic surfactants and/or amphoteric surfactants, and one or more aqueous carriers; wherein the oral composition has a neat pH of from about 9.0 to about 10.5 and a total water content of from about 5% to about 20%. The invention may also include polyethylene glycol, an alkali metal bicarbonate salt, and xylitol.

Abstract: Oral compositions, such as oral gels, toothpastes and mouthwashes, containing a tartaric acid chelating agent and a hydrophobic anionic surfactant.

Abstract: Oral compositions, such as oral gels, toothpastes and mouthwashes, containing a chelating agent and a hydrophobic anionic surfactant.

Abstract: Pharmaceutical composition suitable for coating comprising a composition for oral administration in unit dosage form wherein said composition has been coated with from about 0.01% to about 10% by weight of the composition with a volatile aromatic compound selected from the group consisting of 3-1-menthoxy propane-1,2-diol, N-substituted-p-menthane-3-carboxamides and acyclic carboxamides and mixtures thereof.

Abstract: The subject invention encompasses methods for prevention and treatment of a human or lower animal subject having a urogenital disorder caused or mediated by one or more parasitic protozoa comprising administering to the subject bismuth and one or more antimicrobials. The subject invention also encompasses compositions comprising bismuth and one or more antimicrobials for the prevention and treatment of a human or lower animal subject having a urogenital disorder caused or mediated by one or more parasitic protozoa.

Abstract: An oral composition in the form of a toothpaste, powder, liquid dentifrice, mouthwash, denture cleanser, chewing gum or candy comprising one or more oral composition components selected from abrasives, binders, humectants, surfactants, fluoride ion sources, anticalculus agents and sweeteners and additionally comprising a dimethicone polyol as herein defined.

Abstract: The present invention relates to an oral compositions comprising a soluble fluoride ion source, tetrasodium pyrophosphate, calcium peroxide, and one or more aqueous carriers, wherein the oral composition has a neat pH of from about 9.0 to about 10.5 and a total water content of from about 9.1% to about 20%. The invention may also include an alkali metal bicarbonate salt and xylitol.

Abstract: The present invention relates to a dentifrice formulation comprising first and second dentifrice compositions and to a dentifrice formulation that is a single dentifrice composition. The first dentifrice composition or the single dentifrice composition will comprise from about 0.1% to about 10% of a surfactant selected from the group consisting of anionic surfactants, cationic surfactants, amphoteric surfactants, and mixtures thereof; from about 0.1% to about 10% of a charged polymer; and from about 80% to about 99% of one or more aqueous carriers; wherein the charged polymer is diluted to form a charged polymer slurry and the pH of the charged polymer slurry is from about 1.5 to about 10, the charged polymer slurry is combined with the anionic, cationic, or amphoteric surfactant to form a coacervate gel, and the coacervate gel is then combined with the one or more aqueous carriers to form the dentifrice composition.

Abstract: The present invention relates a dentifrice formulation contained in physically separated compartments of a dispenser, comprising a first dentifrice composition having an ionic strength of from about 1,000 .mu.mho to about 50,000 .mu.mho comprising from about 0.1% to about 8% of a polyoxyethylene having a molecular weight of from about 200,000 to about 7,000,000 and from about 92% to about 99.5% of one or more aqueous carriers; and a second dentifrice composition. The present invention also relates to a dentifrice formulation contained in physically separated compartments of a dispenser, comprising a first dentifrice composition having an ionic strength of from about 1,000 .mu.mho to about 50,000 .mu.mho; and a second dentifrice composition comprising from about 0.1% to about 8% of a polyoxyethylene having a molecular weight of from about 200,000 to about 7,000,000 and from about 92% to about 99.9% of one or more aqueous carriers.

Abstract: The method of manufacturing comprises the steps of: (a) preparing a mixture of a favor system, one or more humectants, and one or more aqueous carrier materials; (b) adding tetrasodium pyrophosphate and calcium peroxide, all at once or in portions, under conditions wherein less than about 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture; and wherein further any remaining aqueous carrier materials not added to the mixture during step (a) are added in whole or in part in step (b) or thereafter, either by themselves or with any remaining amount of the tetrasodium pyrophosphate or calcium peroxide, under conditions such that less than about 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture; (c) heating the mixture to a temperature range of from about 38.degree. C. (100.degree. F.) to about 71.degree. C. (160.degree. F.) and preferably to a temperature range of from about 52.degree. C. (125.degree. F.) to about 57.degree. C. (135.degree. F.

Abstract: Compositions comprising a calcium channel blocker as an active agent and a biocompatible carrier for fixing the agent temporarily at the site of application, or precursor compounds forming such a biocompatible carrier "in situ".It is useful for the treatment of a body site to enhance tissue healing and regeneration, particularly in dental medicine and in surgery.

Abstract: The present invention relates to methods and compositions for prevention or treatment of bone loss due to periodontal disease, oral osseous surgery, periodontal flap surgery, tooth extraction, dental implants, or scaling and root planing comprising topical administration, to mucosal tissues of the oral cavity, of a composition having from about 0.001% to about 0.2% ketorolac in the oral cavity.

Abstract: The present invention relates to a powder, odor absorbing composition, which is safe for use on human skin comprising from about 0.1% to about 25%, by weight of the composition, of uncomplexed cyclodextrin; and a powder carrier. The odor absorbing compositions of the present invention may also contain an additional odor controlling agent, selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants.The present invention also relates to methods of using the compositions of the present invention to reduce body odor and/or vaginal odor.

Abstract: The present invention relates to a method of manufacturing predominately undissolved pyrophosphate and calcium peroxide compositions comprising the steps of: (a) preparing a mixture of a soluble fluoride ion source and one or more aqueous carrier materials; (b) adding tetrasodium pyrophosphate and calcium peroxide, all at once or in portions, under conditions wherein less than about 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture, and wherein any further remaining aqueous carrier materials not added to the mixtures during step (a) are added in whole or in part in step (b) or thereafter, either by themselves or with any remaining amount of the tetrasodium pyrophosphate or calcium peroxide under conditions such that less then about 20% of the total pyrophosphate and calcium peroxide are dissolved in the mixture; and (c) heating the mixture.

Abstract: The present invention relates to a method for inhibiting an undesirable taste in oral compositions such as foods, beverages, and pharmaceuticals. The present invention also relates to oral and pharmaceutical compositions comprising undesirable tasting compounds wherein undesirable tastes are inhibited by the addition of a phosphorylated amino acid, such as phosphotyrosine, phosphoserine, phosphothreonine, and mixtures thereof, to said oral and pharmaceutical compositions.

Abstract: The present invention relates to topical aromatic releasing compositions containing one or more volatile aromatic compounds selected from the group consisting of 3-1-menthoxy propane-1,2-diol, N-substituted-p-menthane-3-carboxamides and acyclic carboxamides and mixtures thereof. In further embodiments, these compositions are also useful for providing relief from nasal symptoms.

Abstract: The invention is drawn to a denture cleaning composition which comprises 1) an inorganic persalt bleaching agent, 2) an effervescence generator, 3) a dimethicone copolyol selected from the group consisting of alkyl- and alkoxy- dimethicone copolyols having the formula (I) as set forth in the specification, and 4) optionally an organic peroxyacid bleach precursor.

Abstract: Disclosed are methods for treatment of herpes virus infections in a human or lower animal subject comprising administering to the subject stannous salt and one or more pharmaceutically acceptable carriers suitable for topical administration. The stannous salt may be one or more stannous carboxylates, a stannous halide selected from the groups consisting of stannous bromide, stannous iodide, and stannous chloride dihydrate, two or more stannous halides, or one or more stannous halides and one or more stannous carboxylates. Another therapeutic agent, such as an anesthetic, analgesic, or antibiotic, may also be administered. Also disclosed are compositions effective in treating herpes virus infections in a human or lower animal subject comprising stannous fluoride, one or more therapeutic agents, and one or more pharmaceutically acceptable carriers suitable for topical administration.